PHYSICIANS SYMPOSIUM
EMERGING TREATMENT PARADIGMS IN MULTIPLE MYELOMA: TARGETING THE NEIGHBORHOOD AND BEYOND – Kenneth Anderson, MD
STATE OF THE ART: 2020 EMERGING THERAPIES IN HEMATOLOGIC MALIGNANCIES – Ruemu E. Birhiray, MD. Chair
BAD BLOOD: TREATMENT OF COMPLIMENTINOPATHIES AND APLASTIC ANEMIA – Robert Brodsky, MD
WHO, WHEN AND HOW TO TREAT: THE PARADOX OF WATCHING, TREATMENT AND RETREATMENT IN INDOLENT LYMPHOMAS IN 2020 – Bruce Cheson, MD, FACP, FAAS, FASCO
HOW I TREAT: THE PRACTICE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN 2020 – Richard Childs, MD, RADM, USPHS
CHRONIC LYMPHOCYTIC LEUKEMIA: WHO, WHEN AND HOW TO TREAT IN 2020 – Steven Coutre, MD
NOVEL THERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIA: DRIVERS, CARS AND TARGETED THERAPY – Hagop Kantarjian, MD
BENIGN HEMATOLOGY: CURRENT TREATMENT OF CYTOPENIAS AND COAGULOPATHIES – Craig Kessler, MD
CURRENT TREATMENT STRATEGIES OF MYELOPROLIFERATIVE NEOPLASMS – Rami Komrokji, MD
CHRONIC MYELOID LEUKEMIA: THERAPEUTIC GOALS AND MANAGING RESISTANCE – Richard Larson, MD
ACUTE MYELOID LEUKEMIA: PROGNOSTICATION, TARGETING AND SEQUENCING THERAPIES – Charles Schiffer, MD
CURRENT THERAPY IN AGGRESSIVE B AND T CELL LYMPHOMAS: AN UPDATE – Sonali Smith, MD
T. HOWARD LEE KEYNOTE LECTURE: IMMUNOTHERAPY HEMATOLOGIC MALIGNANCIES: THERAPEUTIC CELLULAR IMMUNOTHERAPY – Edward Stadtmauer, MD
MYELODYSPLASTIC SYNDROME: WHAT IS NEW IN 2020? – Richard Stone, MD
WALDENSTRÖM’S MACROGLOBULINEMIA: CHOOSING WISELY IN PROGNOSTICATION AND TREATMENT IN 2020 – Steven Treon, MD, MA, PhD, FACP, FRCP
CHALLENGING CASES PRESENTATION – Michael C. Wiemann, MD, FACP – Co-Chair
Hematologic Malignancies Town Hall – Ruemu E. Birhiray, MD. Chair
NURSING SYMPOSIUM
INDOLENT LYMPHOMAS AND HODGKIN’S LYMPHOMA – Bruce Cheson, MD, FACP, FAAS, FASCO
MULTIPLE MYELOMA AND WALDENSTRÖM’S – Morie Gertz, MD
BENIGN HEMATOLOGY AND COAGULOPATHY – Craig Kessler, MD
MYELOPROLIFERATIVE NEOPLASMS: DIAGNOSIS, PROGNOSTICATION AND TREATMENT OPTIONS – Rami Komrokji, MD
MANAGEMENT OF LONG-TERM SURVIVORS OF HEMATOLOGIC MALIGNANCIES – Kristi Orbaugh, RN, MSN RNP, AOCN
MANAGING DRUG INTERACTION WITH ORAL ONCOLYTICS IN THE MANAGEMENT OF HEMATOLOGIC MALIGNANCIES – David Reeves, PharmD, BCOP
Aggressive Lymphomas – Sonali Smith, MD